
Markets
What is 'probability of backtest overfitting,' and how is it actually measured?
A diagnostic built to answer one question a good Sharpe ratio can't: how much of a backtested strategy's performance is signal, and how much is the number of…
Markets coverage from UZU NEWS.

A diagnostic built to answer one question a good Sharpe ratio can't: how much of a backtested strategy's performance is signal, and how much is the number of…

A spread decomposes into processing cost, inventory risk and adverse selection — and each component behaves differently when markets speed up.

Volume counts transactions, not conviction — and the modern tape's count includes flows that carry no opinion at all.

Extended sessions run on thinner books, and the measurable cost shows up in spreads, depth and fill quality — not in headline prices.

Inclusion effects are measurable around the announcement and the effective date — and the two windows tell different stories.